News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Shire Pharmaceuticals Group plc (SHPGY) Vyvanse Drug Disappointment Hits Shares



4/25/2008 6:16:18 AM

LONDON, April 25 (Reuters) - Britain's Shire Plc said on Friday that 2008 sales of its biggest drug hope, Vyvanse for attention deficit hyperactivity disorder (ADHD), would be at the lower end of its expectations, hitting its shares.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES